Back to article
SpringerLink

National Poison Center Trends in GLP-1 Receptor Agonist Exposures Following FDA Approval for Weight Loss - Journal of Medical Toxicology (opens in new tab)

Covered by 3 sources See all sources covering this story including StudyFinds, Medical Xpress

Covered in 3 articles

StudyFinds·

Poison Center Calls For Semaglutide Weight-Loss Drugs More Than Doubled After FDA Approval

Feeds
Medical Xpress·

GLP-1 weight-loss boom linked to surge in poison control calls

Feeds
easternherald.com·

GLP-1 Weight-Loss Boom Linked to Surge in Poison Control Calls, Most Avoidable

Feeds

Keyboard Shortcuts

Navigation

Next / previous post
j/k
Open post
oorEnter
Preview post
v

Post Actions

Love post
a
Like post
l
Dislike post
d
Undo reaction
u
Save / unsave
s

Recommendations

Add interest / feed
Enter
Not interested
x

Go to

Home
gh
Interests
gi
Feeds
gf
Likes
gl
History
gy
Changelog
gc
Settings
gs
Discover
gb
Search
/

General

Show this help
?
Submit feedback
!
Close modal / unfocus
Esc

Press ? anytime to show this help